Extensive apoptosis in ductal carcinoma in situ of the breast

Cancer

Volumn 77, Issue 9, 1996, Pages 1831-1835

  Bodis, Stephan ^a,b,d   Siziopikou, Kalliopi P ^c   Schnitt, Stuart J ^c   Harris, Jay R ^b   Fisher, David E ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

DCIS; necrosis; screening mammography

Indexed keywords

APOPTOSIS; ARTICLE; BREAST CARCINOMA; BREAST DUCT; CANCER INVASION; CANCER SCREENING; CARCINOMA IN SITU; CELL DEATH; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; MAMMOGRAPHY; NECROSIS; PARTIAL MASTECTOMY; PRIORITY JOURNAL;

APOPTOSIS; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CELL DEATH; CELL DIVISION; CELL NUCLEUS; COLORING AGENTS; DEOXYURACIL NUCLEOTIDES; DISEASE PROGRESSION; DNA DAMAGE; DNA NUCLEOTIDYLEXOTRANSFERASE; FEMALE; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; MUTATION; NECROSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS;

EID: 0029915677     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960501)77:9<1831::AID-CNCR11>3.0.CO;2-0     Document Type: Article

References (33)

1. Schnitt SJ, Silen W, Sadowsky NS, Connolly JL, Harris JR. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med 1990;318:898-903.
2. Solin LJ, Yeh IT, Kurtz J, Fourquet A, Recht A, Kuske R, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast conserving surgery and definitive irradiation. Correlation of pathological parameters with outcome of treatment. Cancer 1993;71:2532-42.
3. Recht A, van Dongen JA, Fentiman IS, Holland R, Peterse JL Third meeting of the DCIS working party of the EORTC - conference report. Eur J Cancer 1994;30A:1895-901.
4. Harris JR, Lippman ME, Veronesi O, Willet W. Breast cancer, part two. N Engl J Med 1992;327:390-8.
5. Fisher B, Constantino J, Redmond C. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581-6.
6. Lagios MD, Westdahl PR, Margolin FR, Rose MR. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982;50:1309-14.
7. Schwartz GF, Finkel GC, Garcia JC, Patchefsky AS. Subclinical ductal carcinoma in situ of the breast: treatment by local excision and surveillance alone. Cancer 1992;70:2468-74.
8. Hetelekidis S, Schnitt SJ, Morrow M, Harris JR. Management of ductal carcinoma-in-situ. Ca: a Cancer Journal for Clinicians 1995;45(4):244-53.
9. Fisher ER, Costantino I, Fisher B, Palekar AS, Redmond C, Mamounas E. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Cancer 1995;75:1310-9.
10. Wyllie AH. The biology of cell death in tumours. Anticancer Res 1985;5:131-6.
11. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, et al. Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992;69:119-28.
12. Symonds H, Krall L, Remington L, Saenz-Robles M, Loew S, Jacks T, et al. 53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994;78:703-12.
13. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539-42.
14. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239.
15. Cohen JJ. Overview: mechanisms of apoptosis. Immunol Today 1993;14:126-30.
16. Duvall E, Wyllie AH. Death and the cell. Immunol Today 1986;7:115-9.
17. Martin SJ. Apoptosis: suicide, execution or murder? Trends Cell Biol 1993;3:141-4.
18. Gavrieli Y, Sherman Y, BenSasson A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cel Biol 1992;119:493-501.
19. Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In Situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. Hepatology 1995;21:1465-8.
20. Gorczyca W, Bigman K, Mittelman A, Ahmed T, Gong J, Melamed MR, et al. Induction of DNA strand breaks associated with apoptosis during treatment of leukemias. Leukemia 1993;7:659-70.
21. Holland R, Hendricks J, Verbeek A, Mravunac M, Schuurmans-Stekhoven J. Extent, distribution, and mammographic/histologic correlations of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
22. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618-24.
23. Poller DN, Silverstein MJ, Galea M, Locker AP, Elston CW, Blarney RW, et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification, association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol 1994;7:257-62.
24. Lohmann D, Ruhri C, Schmitt M, et al. Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Diagn Mol Pathol 1993;2:36-41.
25. Bhargava V, Thor A, Deng G. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol 1994;7:361-8.
26. Lipponen P, Aaltomaa S, Kosma VM, Syrjaenen K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur J Cancer 1994;30A:2068-73.
27. Hermeking H, Eick D. Mediation of c-Myc-induced apoptosis by p53. Science 1994;265:2091-3.
28. Wagner AJ, Kokontis JM, Hay N. Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1. Genes Dev 1994;8:2817-30.
29. Boudreau N, Sympson C, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 1995;267:891-3.
30. O'Malley FP, Vnencak-Jones CL, Dupont WD, Paul F, Manning S, Page DL. p53 mutations are confined to comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. Lab Invest 1994;71:67-72.
31. Poller DN, Roberts EC, Bell JA. p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor c-erbG-2 protein. Hum Pathol 1993;24:463-8.
32. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-67.
33. Lowe S, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994;266:807-10.